About Us

Fibronostics is a global diagnostics company, shaping the future of noninvasive diagnostics with artificial intelligence that provides algorithm-based solutions in a variety of diagnostic testing areas, focusing on screening, progression and prognosis of liver & kidney disease, and other chronic conditions. (HBV, HCV, NAFLD, NASH, and ALD).

The company is incorporated in Singapore & New York and is currently commercialized in North America, Asia, Europe and LATAM. Fibronostics is a SPRIM portfolio company with a pedigree in worldwide health innovation, research & consulting.

Fibronsotics mission

Our Mission

To improve human health with the science of diagnostic algorithm and artificial intelligence.

Management Team

Roni Amiel Fibronostics CEO

Roni H. Amiel

Chief Executive Officer

Chief Medical Officer Fibronostics

Dr. Ronald Quiambao

Chief Medical Officer

Chief Financial Officer Fibronostics

Dr. Mona Munteanu

Chief Scientific Officer

Chief Financial Officer Fibronostics

Sylvain Goblet

Chief Operating Officer

Chief Financial Officer Fibronostics

Thomas Fratacci

Chief Financial Officer

Chief Financial Officer Fibronostics

Owen Parr

Vice President Sales (US)

Board of Directors

Business Development Manager Fibronostics

Michael Shleifer PhD

Co-founder and Managing Partner

Business Development Manager Fibronostics

Aditya Mathur

Managing Director Elev8.VC


Business Development Manager Fibronostics

Neil Parekh

Head of Tikehau IM APAC


Scientific Advisors

Founder and Retired President Health Plan Alliance Fibronostics

Cathy Eddy

Founder and Retired President Health Plan Alliance


Clinical Associate Professor of Medicine Texas A&M University

Dr. Imtiaz Alam

Clinical Associate Professor of Medicine Texas A&M University

Clinical Associate Professor of Medicine Texas A&M University

Dr. Stephen A. Harrison

Medical Director of Pinnacle Clinical Research


Medical Technology SPRIM VENTURES

Sven Henrichwark

Medical Technology SPRIM VENTURES


Medical Technology SPRIM VENTURES

Dr. Victor de Lédinghen

Head of the Hepatology & Liver Transplantation Unit, Bordeaux University Hospital

Noninvasive Diagnostic Technology